avmacol
Botanicalexperimental
Clinical trial activity
5 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2016 (NCT02800265)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- avmacol
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05902754 | N/A | Nov 30, 2023 | Louisiana State University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| NCT03399656 | N/A | Jan 10, 2018 | Johns Hopkins University, Qidong Liver Cancer Institute |
| NCT03182959 | Early Phase 1 (Phase 1) | Jul 1, 2017 | National Cancer Institute (NCI), University of Arizona |
| NCT03268993 | N/A | Jun 26, 2017 | University of Pittsburgh |
| NCT02800265 | N/A | Jun 1, 2016 | University of Pittsburgh |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Pittsburgh | Academic/Hospital | 2 | 2 | 1 | 2016 |
| Johns Hopkins University | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Louisiana State University | Academic/Hospital | 1 | 1 | 1 | 2023 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2017 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Government | 1 | 0 | 1 | 2023 |
| Qidong Liver Cancer Institute | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of Arizona | Academic/Hospital | 1 | 1 | 1 | 2017 |
7 organizations
Page 1 / 1